Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Oncology Therapeutics Inc. logo

Principal Accounting Officer Cobo Marc was granted 9,038 shares and covered exercise/tax liability with 203 shares, increasing direct ownership by 167% to 14,141 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBOT (BridgeBio Oncology Therapeutics Inc.) and more on Quantisnow.